Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.33
▲ $2.05 (+0.81%) today
Markets open · 1:56pm ET

JNJ Coverage Page 43

11:18am ET
Health and Healthcare

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes

Johnson & Johnson has announced that it will accelerate initiation of its early stage first-in-human clinical trial for the treatment of COVID-19. Shares got a mild boost on Wednesday from the news.

JNJ
Chris Lange